1-5 of 5
Johannes Vieweg
Close
Sort by
Journal Articles

Delivery of mRNA into Dendritic Cells Using Novel Transfer Peptides Leads to Prolonged Antigen Expression and Potent Immune Responses In Vivo.

Karrune Woan, BS, Axel Heiser, PhD, Philipp Dahm, MD, Johannes Vieweg, MD, Zhen Su, MD
Journal: Blood
Blood (2007) 110 (11): 4884.
https://doi.org/10.1182/blood.V110.11.4884.4884
Published: 2007
Journal Articles

Stimulation of Potent Antigen-Specific T-Cell Responses Using Semiallogenic Dendritic Cells Derived from Human Embryonic Stem Cells.

Zhen Su, MD, Fusheng Wei, Ph.D., Susan Fesperman, Siqing Wang, M.D., Philipp Dahm, M.D., Johannes Vieweg, M.D.
Journal: Blood
Blood (2006) 108 (11): 3704.
https://doi.org/10.1182/blood.V108.11.3704.3704
Published: 2006
Journal Articles

Concomitant Induction of CMVpp65-Specific CD4 + and CD8 + T Cells Using Dendritic Cells Transfected with mRNA Encoding an Invariant Chain-pp65 Fusion Protein.

Ngocdiep Le, MD, PhD, Jens Dannull, PhD, Nelson Chao, MD, Johannes Vieweg, MD
Journal: Blood
Blood (2005) 106 (11): 3243.
https://doi.org/10.1182/blood.V106.11.3243.3243
Published: 2005
Journal Articles

Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand

Jens Dannull, Smita Nair, Zhen Su, David Boczkowski, Christian DeBeck, Benjamin Yang, Eli Gilboa, Johannes Vieweg
Journal: Blood
Blood (2005) 105 (8): 3206–3213.
https://doi.org/10.1182/blood-2004-10-3944
Published: 2005
Journal Articles

Synergy between tumor immunotherapy and antiangiogenic therapy

Smita Nair, David Boczkowski, Benjamin Moeller, Mark Dewhirst, Johannes Vieweg, Eli Gilboa
Journal: Blood
Blood (2003) 102 (3): 964–971.
https://doi.org/10.1182/blood-2002-12-3738
Published: 2003